超声造影能否在动物模型中混合性炎症与纤维化病变的克罗恩病中检测肠壁纤维化
本研究在克罗恩病动物模型中评估超声造影定量灌注参数能否检测混合性炎症与纤维化病变中的肠壁纤维化。31只雌性Lewis大鼠经三硝基苯磺酸-乙醇灌肠诱导肠道病变,最终灌肠后3天行低机械指数超声造影。结果显示超声造影定量参数与肠壁胶原定量无相关性,各组织病理学队列间也无差异。
要点
- 在克罗恩病动物模型中,超声造影定量灌注参数与肠壁胶原定量无相关性(P > .05)。
- 严重炎症伴轻度/无纤维化、中度纤维化和重度纤维化三组间,任何超声造影定量参数均无差异(P > .05)。
- 超声造影定量灌注参数未能有效检测叠加炎症背景下的肠壁纤维化。
核心结论
- 在克罗恩病动物模型中,超声造影定量灌注参数未能有效检测叠加炎症背景下的肠壁纤维化。
研究设计与样本
- 动物实验研究,共纳入31只雌性Lewis大鼠,采用多次(范围1-5次)2,4,6-三硝基苯磺酸-乙醇灌肠创建肠道炎症病变伴不同程度纤维化,最终灌肠后3天经尾静脉注射0.2 mL六氟化硫微泡行低机械指数超声造影,以组织病理学炎症和纤维化评分及Western blotting肠壁胶原定量为参考标准。
诊断标准与关键数值
- 以组织病理学将动物分为3组:严重肠壁炎症/轻度或无纤维化(n=11)、严重肠壁炎症/中度纤维化(n=9)、严重肠壁炎症/重度纤维化(n=11)。
- Western blotting显示不同组织病理学队列间肠壁胶原存在显著差异(P = .0001)。
- 任何超声造影定量参数与肠壁胶原均无相关性(P > .05)。
- 各组织病理学队列间任何超声造影定量参数均无差异(P > .05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether contrast-enhanced sonographic quantitative perfusion parameters can detect bowel wall fibrosis in the setting of mixed inflammatory and fibrotic lesions in a Crohn disease animal model.
METHODS: This study was approved by the institutional Committee on the Use and Care of Animals. Multiple (range, 1-5) 2,4,6-trinitrobenzenesulfonic acid-ethanol enemas were used to create intestinal inflammatory lesions with variable fibrosis in female Lewis rats. Low-mechanical index contrast-enhanced sonography was performed 3 days after the final enema using a 0.2-mL bolus of sulfur hexafluoride microbubbles injected through a tail vein. Contrast-enhanced sonographic data were analyzed with software that converts video data into echo-power (linearized) data. Colorectal lesions were scored for histopathologic inflammation and fibrosis; bowel wall collagen was quantified by Western blotting. The Spearman correlation was used to assess associations between contrast-enhanced sonographic quantitative parameters and bowel wall collagen; the Kruskal-Wallis test was used to compare continuous results between histopathologic groups.
RESULTS: Thirty-one animals were included in our analysis. Animals were placed into 3 histopathologic cohorts: (1) severe bowel wall inflammation/minimal or no fibrosis (n = 11); (2) severe bowel wall inflammation/moderate fibrosis (n = 9); and (3) severe bowel wall inflammation/severe fibrosis (n = 11). Western blotting showed a significant difference in bowel wall collagen between histopathologic cohorts (P = .0001). There was no correlation between any contrast-enhanced sonographic quantitative parameter and bowel wall collagen (P > .05). There was no difference between histopathologic cohorts for any contrast-enhanced sonographic quantitative parameter (P > .05).
CONCLUSIONS: Contrast-enhanced sonographic quantitative perfusion parameters failed to effectively detect bowel wall fibrosis in the setting of superimposed inflammation in a Crohn disease animal model.
引用
- Dillman JR, Rubin JM, Johnson LA, et al. Can Contrast-Enhanced Sonography Detect Bowel Wall Fibrosis in Mixed Inflammatory and Fibrotic Crohn Disease Lesions in an Animal Model? J Ultrasound Med. 2017. PMID: 28072481. doi:10.7863/ultra.16.04064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。